Bio-Techne is trading with Price: unavailable and % Change: unavailable in after-hours trading; its September 23, 2026 special shareholder meeting will vote on Merck KGaA’s proposed $73-per-share cash acquisition.
- Bio-Techne announced a Düsseldorf customer experience center on September 22, which appears less financially material.
- The historical-price feed failed; no reliable after-hours quote was provided, and the movement’s magnitude and direction cannot be independently confirmed.